![](/img/cover-not-exists.png)
Novel agents improve survival of transplant patients with multiple myeloma including those with high-risk disease defined by early relapse (
Venner, Christopher P., Connors, Joseph M., Sutherland, Heather J., Shepherd, John D., Hamata, Linda, Mourad, Yasser Abou, Barnett, Michael J., Broady, Raewyn, Forrest, Donna L., Hogge, Donna E., NantVolume:
52
Language:
english
Journal:
Leukemia & Lymphoma
DOI:
10.3109/10428194.2010.531409
Date:
January, 2011
File:
PDF, 518 KB
english, 2011